Access to monoclonal antibodies in Africa: A call to action

Monoclonal antibodies (mAbs) have transformed modern medicine [1]. However, their impact is limited as they are not accessible to all. In 2020 IAVI and Wellcome published a joint report “Expanding access to monoclonal antibody — based products: a global call to action” [2] which highlighted the gaps and opportunities to expand access to mAbs in low- and middle-income countries (LMICs). The report revealed that few, if any, mAbs were available in LMICs,

Main Topic: 
Mark Content Private(Internal): 
External URL: 
https://www.iavi.org/wp-content/uploads/2024/12/Access-to-monoclonal-antibodies-in-Africa.pdf
Email Alert: 
37
Publication Date: 
17/12/2024
Document Type: